A phase 2, randomized dose-finding study of tapinarof (GSK2894512 Cream) for the treatment of atopic dermatitis
Journal of the American Academy of Dermatology | Jul 08, 2018
Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial
Journal of the American Academy of Dermatology | Jul 07, 2018
Ixekizumab provides superior efficacy compared to ustekinumab over 52-weeks of treatment: Results from IXORA-S, a phase 3 study
Journal of the American Academy of Dermatology | Jul 05, 2018
Natural history of disease activity and damage in patients with cutaneous lupus erythematosus
Journal of the American Academy of Dermatology | Jul 05, 2018